Public Act 099-0654
 
HB5949 EnrolledLRB099 15930 MLM 40247 b

    AN ACT concerning regulation.
 
    Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
 
    Section 5. The Pharmacy Practice Act is amended by changing
Section 16c as follows:
 
    (225 ILCS 85/16c)
    (Section scheduled to be repealed on January 1, 2017)
    Sec. 16c. Medicine locking closure package.
    (a) As used in this Section:
    "Medicine locking closure package" means any alphanumeric
combination locking closure mechanism that can only be unlocked
with a user-generated, resettable alphanumeric code in
combination with an amber prescription container that forms a
package that allows only the person with a prescription access
to the medicine.
    "Schedule II controlled substance" means a Schedule II
controlled substance under the United States Controlled
Substances Act and 21 CFR 1308.
    (b) Subject to appropriation, effective January 1, 2016,
the Department shall by rule implement a pilot project
requiring that every new or refilled prescription for a
Schedule II controlled substance containing hydrocodone
dispensed by a pharmacy that voluntarily decides to participate
in the pilot program shall only be dispensed in a non-reusable
medicine locking closure package. The Department shall not
expend more than $150,000 on this pilot program. The Department
may contract with third parties to implement the pilot program
in whole or in part.
    (c) The medicine locking closure package must be dispensed
by the pharmacy with instructions for patient use unless the
prescriber indicates orally, in writing, or electronically
that a medicine locking closure package shall not be used.
    (d) The manufacturer of the medicine locking closure
package must make available assistance online or through a
toll-free number for patient use.
    (e) Prescriptions reimbursed via the Medicare Part D and
Medicaid programs, including Medicaid managed care plans, are
exempt from the provisions of this Section.
    (f) Prescriptions for individuals residing in facilities
licensed under the Nursing Home Care Act are exempt from the
provisions of this Section.
    (g) This Section is repealed on January 1, 2018 2017.
(Source: P.A. 99-473, eff. 8-27-15.)
 
    Section 99. Effective date. This Act takes effect upon
becoming law.